Cargando…
Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit?
Although coronavirus disease 2019 (COVID-19) is regarded as an acute, resolving infection followed by the development of protective immunity, recent systematic literature review documents evidence for often highly prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222868/ https://www.ncbi.nlm.nih.gov/pubmed/33331810 http://dx.doi.org/10.1099/jgv.0.001545 |
_version_ | 1783711579892613120 |
---|---|
author | Simmonds, Peter Williams, Sarah Harvala, Heli |
author_facet | Simmonds, Peter Williams, Sarah Harvala, Heli |
author_sort | Simmonds, Peter |
collection | PubMed |
description | Although coronavirus disease 2019 (COVID-19) is regarded as an acute, resolving infection followed by the development of protective immunity, recent systematic literature review documents evidence for often highly prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory and faecal samples, periodic recurrence of PCR positivity in a substantial proportion of individuals and increasingly documented instances of reinfection associated with a lack of protective immunity. This pattern of infection is quite distinct from the acute/resolving nature of other human pathogenic respiratory viruses, such as influenza A virus and respiratory syncytial virus. Prolonged shedding of SARS-CoV-2 furthermore occurs irrespective of disease severity or development of virus-neutralizing antibodies. SARS-CoV-2 possesses an intensely structured RNA genome, an attribute shared with other human and veterinary coronaviruses and with other mammalian RNA viruses such as hepatitis C virus. These are capable of long-term persistence, possibly through poorly understood RNA structure-mediated effects on innate and adaptive host immune responses. The assumption that resolution of COVID-19 and the appearance of anti-SARS-CoV-2 IgG antibodies represents virus clearance and protection from reinfection, implicit for example in the susceptible–infected–recovered (SIR) model used for epidemic prediction, should be rigorously re-evaluated. |
format | Online Article Text |
id | pubmed-8222868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Microbiology Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-82228682021-06-24 Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? Simmonds, Peter Williams, Sarah Harvala, Heli J Gen Virol Insight Review Although coronavirus disease 2019 (COVID-19) is regarded as an acute, resolving infection followed by the development of protective immunity, recent systematic literature review documents evidence for often highly prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory and faecal samples, periodic recurrence of PCR positivity in a substantial proportion of individuals and increasingly documented instances of reinfection associated with a lack of protective immunity. This pattern of infection is quite distinct from the acute/resolving nature of other human pathogenic respiratory viruses, such as influenza A virus and respiratory syncytial virus. Prolonged shedding of SARS-CoV-2 furthermore occurs irrespective of disease severity or development of virus-neutralizing antibodies. SARS-CoV-2 possesses an intensely structured RNA genome, an attribute shared with other human and veterinary coronaviruses and with other mammalian RNA viruses such as hepatitis C virus. These are capable of long-term persistence, possibly through poorly understood RNA structure-mediated effects on innate and adaptive host immune responses. The assumption that resolution of COVID-19 and the appearance of anti-SARS-CoV-2 IgG antibodies represents virus clearance and protection from reinfection, implicit for example in the susceptible–infected–recovered (SIR) model used for epidemic prediction, should be rigorously re-evaluated. Microbiology Society 2020-12-17 /pmc/articles/PMC8222868/ /pubmed/33331810 http://dx.doi.org/10.1099/jgv.0.001545 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution. |
spellingShingle | Insight Review Simmonds, Peter Williams, Sarah Harvala, Heli Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title | Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title_full | Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title_fullStr | Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title_full_unstemmed | Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title_short | Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? |
title_sort | understanding the outcomes of covid-19 – does the current model of an acute respiratory infection really fit? |
topic | Insight Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222868/ https://www.ncbi.nlm.nih.gov/pubmed/33331810 http://dx.doi.org/10.1099/jgv.0.001545 |
work_keys_str_mv | AT simmondspeter understandingtheoutcomesofcovid19doesthecurrentmodelofanacuterespiratoryinfectionreallyfit AT williamssarah understandingtheoutcomesofcovid19doesthecurrentmodelofanacuterespiratoryinfectionreallyfit AT harvalaheli understandingtheoutcomesofcovid19doesthecurrentmodelofanacuterespiratoryinfectionreallyfit |